Pharma Foods International Co Ltd
TSE:2929
Intrinsic Value
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. [ Read More ]
The intrinsic value of one
Pharma Foods International Co Ltd
stock under the Base Case scenario is
2 855.99
JPY.
Compared to the current market price of 808 JPY,
Pharma Foods International Co Ltd
is
Undervalued by 72%.
Pharma Foods International Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Pharma Foods International Co Ltd's market capitalization is 22.7B JPY.
Pharma Foods International Co Ltd stock price is 808 JPY.
Pharma Foods International Co Ltd stock price (808 JPY) is 72% less than its Intrinsic Value (2 855.99 JPY).
Pharma Foods International Co Ltd stock price (808 JPY) is 21% less than its DCF Value (1 026.76 JPY). Open DCF Valuation
Pharma Foods International Co Ltd stock price (808 JPY) is 83% less than its Relative Value (4 685.22 JPY). Open Relative Valuation
Pharma Foods International Co Ltd has upside potential of 271% compared to the average analyst price target.
Open Wall St Estimates
Pharma Foods International Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 24% to 25%.
Pharma Foods International Co Ltd's Revenue has dropped by 2% over the past 12 months.
Pharma Foods International Co Ltd's short-term assets (28B JPY) exceed its short-term liabilties (26B JPY).
Pharma Foods International Co Ltd has positive Operating Income for the last twelve months.
Pharma Foods International Co Ltd has positive Free Cash Flow for the last twelve months.
Pharma Foods International Co Ltd's long-term assets (37B JPY) exceed its long-term liabilties (28B JPY).
Pharma Foods International Co Ltd has positive Net Debt. This means that the company has more debt (19B JPY) than cash and short-term investments (17B JPY).
Pharma Foods International Co Ltd has positive Net Income for the last twelve months.
Pharma Foods International Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 25%.
Pharma Foods International Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from 51% to 64%.
Pharma Foods International Co Ltd has positive three-year average ROIC (Return on Invested Capital): 18%. The company is efficient at using invested capital to generate operating income.
Pharma Foods International Co Ltd's D/E (Debt to Equity) is very high and is equal to 2.06.
Pharma Foods International Co Ltd's Revenue has been growing by an exceptional 30% per year for the last 3 years.
Pharma Foods International Co Ltd's Altman Z-Score is very high and is equal to 3.22.
Pharma Foods International Co Ltd's ROE (Return on Equity) for the past 12 months is very high and is equal to 64%.
Pharma Foods International Co Ltd has positive Gross Profit for the last twelve months.
Pharma Foods International Co Ltd has very high three-year average ROE (Return on Equity): 36%. The company is very efficient at transforming stockholders' equity into net income.
Pharma Foods International Co Ltd earns more than enough operating income (6B JPY) to safely cover interest payments on its debt (48m JPY).
Valuation Backtest
Pharma Foods International Co Ltd
Run backtest to discover the historical profit from buying and selling
Pharma Foods International Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Pharma Foods International Co Ltd
Balance Sheet Decomposition
Pharma Foods International Co Ltd
| Current Assets | 27.7B |
| Cash & Short-Term Investments | 17B |
| Receivables | 4B |
| Other Current Assets | 6.7B |
| Non-Current Assets | 9.3B |
| Long-Term Investments | 2.7B |
| PP&E | 4.6B |
| Intangibles | 215m |
| Other Non-Current Assets | 1.8B |
| Current Liabilities | 25.8B |
| Accounts Payable | 1B |
| Accrued Liabilities | 80m |
| Short-Term Debt | 17.4B |
| Other Current Liabilities | 7.3B |
| Non-Current Liabilities | 2B |
| Long-Term Debt | 1.5B |
| Other Non-Current Liabilities | 459m |
Earnings Waterfall
Pharma Foods International Co Ltd
|
Revenue
|
65.1B
JPY
|
|
Cost of Revenue
|
-13.1B
JPY
|
|
Gross Profit
|
52B
JPY
|
|
Operating Expenses
|
-46B
JPY
|
|
Operating Income
|
6B
JPY
|
|
Other Expenses
|
-1.3B
JPY
|
|
Net Income
|
4.8B
JPY
|
Free Cash Flow Analysis
Pharma Foods International Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Pharma Foods International Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Pharma Foods International Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Pharma Foods International Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Pharma Foods International Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Pharma Foods International Co Ltd
According to Wall Street analysts, the average 1-year price target for
Pharma Foods International Co Ltd
is 3 000 JPY
.
Shareholder Return
Price
Pharma Foods International Co Ltd
| Average Annual Return | 74.85% |
| Standard Deviation of Annual Returns | 171.44% |
| Max Drawdown | -78% |
| Market Capitalization | 22.7B JPY |
| Shares Outstanding | 28 845 006 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Pharma Foods International Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
Contact
IPO
Employees
Officers
The intrinsic value of one
Pharma Foods International Co Ltd
stock under the Base Case scenario is
2 855.99
JPY.
Compared to the current market price of 808 JPY,
Pharma Foods International Co Ltd
is
Undervalued by 72%.
You don't have any saved screeners yet
